Endometrial Thickness and Subendometrial Vascularity in Anovulatory Polycystic Ovarian Syndrome Patients Treated by Metformin
Endometrial Thickness and Subendometrial Vascularity in Anovulatory Polycystic Ovarian Syndrome Patients Treated by Metformin
The participants will receive metformin 500mg 3times per day for 3months and one month is
 left for spontaneous pregnancy to occur or not (primary outcome ) and the investigators will
 check endometrial thickness and subendometerial vascularity as markers of endometrial
 receptivity before and after the treatment.
Inclusion Criteria:

 -  PCO syndrome patients have the following criteria:

 Age of the patient between 20 - 40 years old. All subjects are not on a specific diet nor a
 certain program of physical exercise Complaining of infertility either primary or secondary
 due to PCOS.

 N.B: The diagnosis of PCO syndrome was made according to the Androgen Excess and Polycystic
 Ovarian Syndrome Society: the presence of the following criteria have been required for the
 diagnosis of PCO syndrome:

 Hyperandrogenism: Hirsutism and/or Hyperandrogenaemia Ovarian Dysfunction :
 Oligo-Anovulation and /or Polycystic ovaries Exclusion of other Androgen Excess or related
 disorders as :( deficient nonclassic adrenal hyperplasia, androgen-secreting neoplasms,
 androgenic/anabolic drug use or abuse, Cushing's syndrome, the Hyperandrogenic-Insulin
 Resistance-Acanthosis Nigricans syndrome, thyroid dysfunction, and hyperprolactinemia).

 Exclusion Criteria:

 -  Age below 20 or above 40. Women who intended to start a diet or a specific program of
 physical activity. Concurrent medical illness as cardiovascular, neoplastic and
 hepatic disorder. Pelvic pathology. Tubal, Uterine, Male factor of infertility.
 Endocrinological factors including: diabetes Mellitus,hypothyroidism,
 hyperprolactinaemia, Cushing's syndrome, and non- classical congenital adrenal
 hyperplasia.

 Patients who are ovulatory during the ovarian cycle